首页> 外文期刊>Photodiagnosis and Photodynamic Therapy >Oral 5-aminolevulinic acid administration prior to transurethral resection of bladder tumor causes intraoperative hypotension: Propensity score analysis
【24h】

Oral 5-aminolevulinic acid administration prior to transurethral resection of bladder tumor causes intraoperative hypotension: Propensity score analysis

机译:口腔5-氨基乙酰乙酰丙酸给药在经尿道膀胱肿瘤之前导致术中的低血压:倾向评分分析

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Background: Transurethral resection of bladder tumor (TUR-BT) using 5-aminolevulinic acid (5-ALA) is common; however, intraoperative hypotension is frequent. This study aimed to investigate the impact of preoperative oral 5-ALA taking on hypotension and vasopressors dose during general anesthesia, and postoperative nausea and vomiting. Methods: This retrospective study included patients aged = 20 years who had undergone elective TUR-BT for bladder tumors under general anesthesia. An inverse probability of treatment weighted using stabilized inverse propensity scores was adopted to minimize bias. After adjustment based on patient data, outcomes of interest in patients with and without preoperative administration of 5-ALA were compared using a generalized estimating equation. Primary outcomes were hypotension incidence during anesthesia, which was defined as a mean arterial pressure 60 mmHg, and the impact of 5-ALA administration on hypotension. Results: Of 324 patients considered, 153 (47.2 %) received 5-ALA preoperatively. The weighted incidence of hypotension was 23.3 % in patients taking 5-ALA, with an odds ratio of 4.21 (95 % confidence interval 2.07-8.55). Odds ratios (ORs) and 95 % confidence intervals for oral 5-ALA administration were 1.55 (1.23-1.96) for ephedrine, 1.18 (0.66-2.11) for phenylephrine, and 12.3 (5.73-26.5) for postoperative nausea and vomiting. Conclusions: Preoperative oral 5-ALA administration was associated with hypotension during general anesthesia in patients who underwent TUR-BT despite receiving higher doses of ephedrine. Postoperative nausea and vomiting were also more common in these patients.
机译:背景:使用5-氨基乙酰丙烯酸(5-ALA)的膀胱瘤切除膀胱肿瘤(TUR-BT)是常见的;然而,术中的低血压频繁。本研究旨在探讨术前口服5 - ALA服用低血压和血管加压剂剂量的影响,术后恶心和呕吐。方法:该回顾性研究包括患者患者& = 20岁,在全身麻醉下对膀胱肿瘤进行了接受的接口肿瘤。采用使用稳定的逆倾斜分数加权治疗的反比异性以最小化偏差。基于患者数据进行调整后,使用广义估计方程比较患有和不术前施用5 ALA的患者的感兴趣的结果。主要结果是麻醉期间的低血压发生率,其定义为平均动脉压且介质& 60 mmHg,5 - Ala施用对低血压的影响。结果:324例患者占324名患者,术前153名(47.2%)。服用5艾拉的患者的低血压的加权发病率为23.3%,比率为4.21(95%置信区间2.07-8.55)。 ODAS比率(ORS)和95%的口服5-ALA施用的置信度为1.55(1.23-1.96),用于脱氧肾上腺素的1.18(0.66-2.11),12.3(5.73-26.5),用于术后恶心和呕吐。结论:术前口腔5-Ala施用与虽然接受较高剂量的麻黄碱,但在患者中,术前口腔5艾拉局与过度麻醉期间的低血压有关。术后恶心和呕吐在这些患者中也更常见。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号